148 related articles for article (PubMed ID: 2109092)
1. Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes.
Weber JS; Rosenberg SA
J Natl Cancer Inst; 1990 May; 82(9):755-61. PubMed ID: 2109092
[TBL] [Abstract][Full Text] [Related]
2. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
4. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.
Harada M; Matsuzaki G; Shinomiya Y; Kurosawa S; Ito O; Okamoto T; Takenoyama M; Sumitika H; Nishimura Y; Nomoto K
Cancer Immunol Immunother; 1994 May; 38(5):332-8. PubMed ID: 8162615
[TBL] [Abstract][Full Text] [Related]
5. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.
Lafreniere R; Borkenhagen K; Bryant LD; Ng E; Hayton S
J Biol Response Mod; 1990 Feb; 9(1):53-60. PubMed ID: 2181072
[TBL] [Abstract][Full Text] [Related]
6. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
Akbasak A; Oldfield EH; Saris SC
J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes.
Fox BA; Spiess PJ; Kasid A; Puri R; Mulé JJ; Weber JS; Rosenberg SA
J Biol Response Mod; 1990 Oct; 9(5):499-511. PubMed ID: 2174966
[TBL] [Abstract][Full Text] [Related]
8. An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity.
Yang JC; Perry-Lalley D; Rosenberg SA
J Biol Response Mod; 1990 Apr; 9(2):149-59. PubMed ID: 1971302
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
10. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.
Knisely TL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):247-57. PubMed ID: 2154414
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction.
Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
Papa MZ; Mulé JJ; Rosenberg SA
Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
[TBL] [Abstract][Full Text] [Related]
13. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
Weber JS; Rosenberg SA
Cancer Res; 1988 Oct; 48(20):5818-24. PubMed ID: 3139284
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.
Spiess PJ; Yang JC; Rosenberg SA
J Natl Cancer Inst; 1987 Nov; 79(5):1067-75. PubMed ID: 3500355
[TBL] [Abstract][Full Text] [Related]
16. Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer.
Yano T; Yasumoto K; Togami M; Ishida T; Kimura G; Sugimachi K; Nomoto K
Int J Cancer; 1989 Apr; 43(4):619-23. PubMed ID: 2495250
[TBL] [Abstract][Full Text] [Related]
17. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.
Schendel DJ; Gansbacher B
Cancer Res; 1993 Sep; 53(17):4020-5. PubMed ID: 8358731
[TBL] [Abstract][Full Text] [Related]
19. Adoptively transferred tumor-infiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes.
Alexander RB; Rosenberg SA
J Immunother (1991); 1991 Dec; 10(6):389-97. PubMed ID: 1768672
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.
Lefor AT; Fabian DF
J Surg Res; 1998 Feb; 75(1):49-53. PubMed ID: 9614856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
